{
  "num_tested_probands": [
    3,
    3,
    1
  ],
  "num_positive_het_probands": [
    1,
    1,
    1
  ],
  "positive_phenotypes": [
    [
      "prolonged duration of action of succinylcholine",
      "prolonged duration of action of mivacurium"
    ],
    [
      "prolonged duration of action of succinylcholine",
      "apnoea",
      "postoperative artificial ventilation",
      "complete neuromuscular block"
    ],
    [
      "phenotypically abnormal plasma cholinesterase activity"
    ]
  ],
  "num_compound_or_double_hets": [
    2,
    1,
    1
  ],
  "explanation": {
    "num_tested_probands": [
      "The article refers to 'the probands of the three unrelated families', indicating three probands were tested.",
      "The report mentions probands from family 1, family 2, and family 3.",
      "The report refers to a 'patient compound heterozygous for a novel and a known silent mutation', indicating a single proband was tested."
    ],
    "num_positive_het_probands": [
      "From Table: Patient in family 3 is genotype 142M/*328D and phenotype AS (heterozygous for the atypical variant and a silent variant), confirming 1 heterozygous.",
      "Patient 2-3 in family 2 was genotyped as heterozygous for BCHE*FS126.",
      "The same patient is described as compound heterozygous, implying heterozygosity for pathogenic variants."
    ],
    "positive_phenotypes": [
      "The probands were referred due to 'prolonged duration of action of succinylcholine' and 'mivacurium'.",
      "Phenotypes such as 'prolonged duration of action of succinylcholine', 'apnoea', 'postoperative artificial ventilation', and 'complete neuromuscular block' were described in the probands.",
      "The phenotype 'phenotypically abnormal plasma cholinesterase activity' is mentioned in relation to tested probands."
    ],
    "num_compound_or_double_hets": [
      "Patient in family 1 and family 3 are both compound heterozygotes as they have two different mutations (e.g., BCHE*115D*I3E4-14C/*FS126 and 142M/*328D).",
      "Proband in family 3 is described as compound heterozygous for BCHE*328D and BCHE*142M.",
      "The text refers to a 'patient compound heterozygous for a novel and a known silent mutation', specifying one such case."
    ]
  },
  "gene_symbol": [
    [
      "BCHE",
      "CLU",
      "DCR",
      "FST",
      "S12",
      "ST2",
      "UST"
    ],
    [
      "BCHE",
      "C5",
      "CAT",
      "CHE2",
      "GC",
      "PC",
      "S12",
      "S19"
    ],
    [
      "BCHE"
    ]
  ],
  "genomic_hgvs": [
    [],
    [],
    []
  ]
}